Emerging Biotech
Simcere Pharmaceutical Group Licenses First In Class TL1A IL23p19 Bispecific Antibody To Boehringer Ingelheim For Inflammatory Bowel Disease
Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in inflammatory bowel disease. Lice...
January 29, 2026 | News
Kazia Therapeutics Reports Encouraging Early Responses For Paxalisib Combination In Advanced Triple Negative Breast Cancer
Kazia Therapeutics provided a clinical update from its ongoing Phase 1b study evaluating paxalisib in combination with pembrolizumab and chemothe...
January 29, 2026 | News
Skyhawk Therapeutics Reports Positive Nine Month Interim Data For SKY 0515 In Huntington’s Disease
Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 points, compared to natural hi...
January 29, 2026 | News
Ellipses Pharma Limited In Licences First In Class B7H3 Targeted ADC From Innolake Biopharm Co. Ltd To Expand Global Oncology Pipeline
Ellipses Pharma Limited (“Ellipses”), a clinical-stage oncology drug development company with a pipeline of innovative programmes, announced th...
January 26, 2026 | News
Gene Solutions And Pangea Laboratory Partner To Advance US Clinical Validation Of Liquid Biopsy Tests
Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation Sequencing (NGS) leader ...
January 22, 2026 | News
Alteogen Signs Exclusive Global Licensing Deal With GSK Subsidiary Tesaro For ALT B4
Alteogen Inc. (KOSDAQ: 196170) announced that the company has entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of GSK...
January 21, 2026 | News
AstraZeneca Acquires Full Global Rights To CCAR031 From AbelZeta Pharma
AbelZeta Pharma, Inc. ("AbelZeta"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietar...
January 20, 2026 | News
D3 Bio Secures FDA IND Clearances To Advance KRAS G12D And G12C Clinical Programme
D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, announced that the U.S. Foo...
January 20, 2026 | News
AIM Vaccine Advances High Efficiency Diploid Rabies Vaccine Into Final Clinical Stage
AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficie...
January 19, 2026 | News
Immunofoco CAR T Therapy IMC002 Posts Strong Responses In Advanced Gastric And Gej Cancers At Asco Gi 2026
Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from ...
January 15, 2026 | News
ElpasBio And Fosun Kairos Partner To Commercialise AlloJoin Stem Cell Therapy For Knee Osteoarthritis In Greater China
ElpasBio Holdings ("ElpasBio"), a leading clinical-stage biotechnology company focused on regenerative medicine, announced that it has entered into a colla...
January 15, 2026 | News
Animate Biosciences Delivers Ai Designed Peptides That Match Standard Of Care In Pulmonary Fibrosis Model
Animate Biosciences announces positive preclinical results from a mouse model of pulmonary fibrosis demonstrating that two of its AI-designed therapeu...
January 15, 2026 | News
Novartis Secures Worldwide Licence To PepLib Peptide Asset To Expand Radioligand Therapy Pipeline
Zonsen PepLib Biotech Inc. announced that it has entered into a worldwide license agreement with Novartis for an undisclosed peptide-based asset in t...
January 15, 2026 | News
China Approves ArkBio Aizhida For ADHD With Rapid Onset And All Day Symptom Control
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the...
January 12, 2026 | News
Most Read
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
